The total number of records retrieved from this search are 12. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
IDOV_4619	Virus nameAdenovirus	Virus strainAd5/3-CB016	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationMutation in delta E3 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineUniversity of pitsburgh	Origin of cell lineHuman neck and squamous cell carcinoma cell line	Cell lineUPCI SCC 090	Concentration of cell line3000 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration1 VP per cell	In-vitro result100% cell viablity after 3 days	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID27086483
IDOV_4620	Virus nameAdenovirus	Virus strainAd5/3-CB016	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationMutation in delta E3 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineUniversity of pitsburgh	Origin of cell lineHuman neck and squamous cell carcinoma cell line	Cell lineUPCI SCC 090	Concentration of cell line3000 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 VP per cell	In-vitro result100% cell viablity after 3 days	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID27086483
IDOV_4621	Virus nameAdenovirus	Virus strainAd5/3-CB016	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationMutation in delta E3 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineUniversity of pitsburgh	Origin of cell lineHuman neck and squamous cell carcinoma cell line	Cell lineUPCI SCC 090	Concentration of cell line3000 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration100 VP per cell	In-vitro result100% cell viablity after 3 days	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID27086483
IDOV_4622	Virus nameAdenovirus	Virus strainAd5/3-delata 24	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationMutation in delta E3 and delta 24 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineUniversity of pitsburgh	Origin of cell lineHuman neck and squamous cell carcinoma cell line	Cell lineUPCI SCC 090	Concentration of cell line3000 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration1 VP per cell	In-vitro result100% cell viablity after 3 days	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID27086483
IDOV_4623	Virus nameAdenovirus	Virus strainAd5/3-delata 24	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationMutation in delta E3 and delta 24 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineUniversity of pitsburgh	Origin of cell lineHuman neck and squamous cell carcinoma cell line	Cell lineUPCI SCC 090	Concentration of cell line3000 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 VP per cell	In-vitro result100% cell viablity after 3 days	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID27086483
IDOV_4624	Virus nameAdenovirus	Virus strainAd5/3-delata 24	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationMutation in delta E3 and delta 24 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineUniversity of pitsburgh	Origin of cell lineHuman neck and squamous cell carcinoma cell line	Cell lineUPCI SCC 090	Concentration of cell line3000 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration100 VP per cell	In-vitro result40% cell viablity after 3 days	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID27086483
IDOV_4625	Virus nameAdenovirus	Virus strainAd5/3-CB016	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationMutation in delta E3 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineUniversity of pitsburgh	Origin of cell lineHuman neck and squamous cell carcinoma cell line	Cell lineUPCI SCC 090	Concentration of cell line3000 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration1 VP per cell	In-vitro result80% cell viablity after 7 days	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID27086483
IDOV_4626	Virus nameAdenovirus	Virus strainAd5/3-CB016	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationMutation in delta E3 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineUniversity of pitsburgh	Origin of cell lineHuman neck and squamous cell carcinoma cell line	Cell lineUPCI SCC 090	Concentration of cell line3000 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 VP per cell	In-vitro result80% cell viablity after 7 days	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID27086483
IDOV_4627	Virus nameAdenovirus	Virus strainAd5/3-CB016	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationMutation in delta E3 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineUniversity of pitsburgh	Origin of cell lineHuman neck and squamous cell carcinoma cell line	Cell lineUPCI SCC 090	Concentration of cell line3000 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration100 VP per cell	In-vitro result70% cell viablity after 7 days	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID27086483
IDOV_4628	Virus nameAdenovirus	Virus strainAd5/3-delata 24	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationMutation in delta E3 and delta 24 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineUniversity of pitsburgh	Origin of cell lineHuman neck and squamous cell carcinoma cell line	Cell lineUPCI SCC 090	Concentration of cell line3000 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration1 VP per cell	In-vitro result100% cell killing after 7 days	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID27086483
IDOV_4629	Virus nameAdenovirus	Virus strainAd5/3-delata 24	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationMutation in delta E3 and delta 24 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineUniversity of pitsburgh	Origin of cell lineHuman neck and squamous cell carcinoma cell line	Cell lineUPCI SCC 090	Concentration of cell line3000 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration10 VP per cell	In-vitro result100% cell killing after 7 days	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID27086483
IDOV_4630	Virus nameAdenovirus	Virus strainAd5/3-delata 24	Virus genome typeDNA	Virus familyAdenoviridae	Virus genome modificationMutation in delta E3 and delta 24 gene	Virus aloneYes	Virus in combination with drug/radiationNo	Immune gene insertion in viral genomeNo	Source of cell lineUniversity of pitsburgh	Origin of cell lineHuman neck and squamous cell carcinoma cell line	Cell lineUPCI SCC 090	Concentration of cell line3000 cells per well	In-vitro toxicityNA	AssayMTT assay	In-vitro virus concentration100 VP per cell	In-vitro result100% cell killing after 7 days	Model organismNo	In-vivo virus concentrationNo	In-vivo toxicityNA	In-vivo resultNo response	Mode of deliveryNA	Pathway inducedNA	Immunogenic effectNA	Clinical trialNA	PMID27086483